Companies / Neurogene Inc. / Activity
Activity — Neurogene Inc.
22 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Cvijic Christine Mikail Executive | Sell | Common Stock | $120.5K | -5K -4.19% | 109,843 0.55% of shares | medium |
| Mar 13, 2026 | Cobb Stuart Executive | Sell | Common Stock | $81.5K | -4K -10.70% | 33,303 0.17% of shares | low |
| Mar 26, 2026 | McMinn Rachel CEO | Sell | Common Stock | $74.0K | -3K -0.25% | 1,344,307 6.72% of shares | low |
| Mar 13, 2026 | Cobb Stuart Executive | Sell | Common Stock | $56.7K | -3K -7.98% | 30,645 0.15% of shares | low |
| Mar 26, 2026 | Cvijic Christine Mikail Executive | Sell | Common Stock | $55.3K | -3K -2.42% | 103,240 0.52% of shares | low |
| Mar 13, 2026 | Cvijic Christine Mikail Executive | Sell | Common Stock | $48.7K | -2K -2.17% | 107,456 0.54% of shares | low |
| Mar 13, 2026 | Cvijic Christine Mikail Executive | Sell | Common Stock | $29.6K | -1K -1.30% | 106,061 0.53% of shares | low |
| Mar 26, 2026 | Jordan Julie Executive | Sell | Common Stock | $18.1K | -828 -6.23% | 12,472 0.06% of shares | low |
| Mar 13, 2026 | Cvijic Christine Mikail Executive | Sell | Common Stock | $5.8K | -263 -0.25% | 105,798 0.53% of shares | low |
| Mar 13, 2026 | Cobb Stuart Executive | Sell | Common Stock | $3.3K | -148 -0.48% | 30,497 0.15% of shares | low |
| Feb 20, 2026 | McMinn Rachel CEO | Grant | Common Stock | $0 | +26K +1.96% | 1,347,659 6.73% of shares | low |
| Feb 20, 2026 | Cvijic Christine Mikail Executive | Grant | Common Stock | $0 | +22K +23.75% | 114,643 0.57% of shares | low |
| Feb 20, 2026 | Cobb Stuart Executive | Grant | Common Stock | $0 | +17K +79.35% | 37,294 0.19% of shares | low |
| Feb 20, 2026 | Jordan Julie Executive | Grant | Common Stock | $0 | +5K +58.33% | 13,300 0.07% of shares | low |
| Feb 20, 2026 | Freedland Cory S. Director | Grant | Non-Qualified Stock Option (right to buy) | — | +12K | 12,050 0.06% of shares | low |
| Feb 20, 2026 | Noonberg Sarah B. Director | Grant | Non-Qualified Stock Option (right to buy) | — | +12K | 12,050 0.06% of shares | low |
| Feb 20, 2026 | McMinn Rachel CEO | Grant | Stock Option (Right to Buy) | — | +155K | 155,100 0.78% of shares | low |
| Feb 20, 2026 | Cvijic Christine Mikail Executive | Grant | Stock Option (Right to Buy) | — | +132K | 131,900 0.66% of shares | low |
| Feb 20, 2026 | Palekar Rohan Director | Grant | Non-Qualified Stock Option (right to buy) | — | +12K | 12,050 0.06% of shares | low |
| Feb 20, 2026 | Woods Keith Director | Grant | Non-Qualified Stock Option (right to buy) | — | +12K | 12,050 0.06% of shares | low |
| Feb 20, 2026 | Jordan Julie Executive | Grant | Stock Option (Right to Buy) | — | +30K | 29,600 0.15% of shares | low |
| Feb 20, 2026 | Baffi Robert Director | Grant | Non-Qualified Stock Option (right to buy) | — | +12K | 12,050 0.06% of shares | low |